Nevus density and melanoma risk in women: A pooled analysis to test the divergent pathway hypothesis
Open Access
- 19 September 2008
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 124 (4), 937-944
- https://doi.org/10.1002/ijc.24011
Abstract
A “divergent pathway” model for the development of cutaneous melanoma has been proposed. The model hypothesizes that melanomas occurring in people with a low tendency to develop nevi will, on average, arise more commonly on habitually sun‐exposed body sites such as the head and neck. In contrast, people with an inherent propensity to develop nevi will tend to develop melanomas most often on body sites with large melanocyte populations, such as on the back. We conducted a collaborative analysis to test this hypothesis using the original data from 10 case–control studies of melanoma in women (2,406 cases and 3,119 controls), with assessment of the potential confounding effects of socioeconomic, pigmentary and sun exposure‐related factors. Higher nevus count on the arm was associated specifically with an increased risk of melanoma of the trunk (p for trend = 0.0004) and limbs (both upper and lower limb p for trends = 0.01), but not of the head and neck (p for trend = 0.25). The pooled odds ratios for the highest quartile of nonzero nevus count versus none were 4.6 (95% confidence interval (CI) 2.7–7.6) for melanoma of the trunk, 2.0 (95% CI 0.9–4.5) for the head and neck, 4.2 (95% CI 2.3–7.5) for the upper limbs and 3.4 (95% CI 1.5–7.9) for the lower limbs. Aggregate data from these studies suggest that high nevus counts are strongly associated with melanoma of the trunk but less so if at all of the head and neck. This finding supports different etiologic pathways of melanoma development by anatomic site.Keywords
This publication has 61 references indexed in Scilit:
- A comparison of the anatomic distribution of cutaneous melanoma in two populations with different levels of sunlight: the west of Scotland and Queensland, Australia 1982–2001Cancer Causes & Control, 2007
- Number of Nevi at a Specific Anatomical Site and Its Relation to Cutaneous Malignant MelanomaJournal of Investigative Dermatology, 2006
- Risk Factors for Melanoma by Body SiteCancer Epidemiology, Biomarkers & Prevention, 2005
- Quantitative Measures of the Effect of the Melanocortin 1 Receptor on Human Pigmentary Status11Presented in part at ESDR Geneva 2002, Naysmith L, Ha T, Waterston K, et al: Melanocortin 1 receptor accounts for 50% of variation in a Northern European dataset. J Invest Dermatol 119:758, 2002 (abstr).Journal of Investigative Dermatology, 2004
- The naevus count on the arms as a predictor of the number of melanocytic naevi on the whole bodyBritish Journal of Dermatology, 1999
- Lentigo maligna and lentigo maligna melanomaJournal of the American Academy of Dermatology, 1995
- Benign melanocytic lesions: Risk markers or precursors of cutaneous melanoma?Journal of the American Academy of Dermatology, 1995
- Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma: Results of a case control study in melanoma patients and nonmelanoma control subjectsJournal of the American Academy of Dermatology, 1992
- The Danish case‐control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in womenInternational Journal of Cancer, 1988
- Site-specific melanocytic naevus counts as predictors of whole body naeviBritish Journal of Dermatology, 1988